Statistical Genetics
Biology
1 Career
- Since 2026 Professor, Institute of Science and Technology Austria (ISTA)
- 2020 – 2026 Assistant Professor, Institute of Science and Technology Austria (ISTA)
- 2017 – 2020 Assistant Professor, University of Lausanne, Switzerland
- 2013 – 2016 Research Fellow, University of Queensland, Brisbane, Australia
- 2010 – 2013 NERC Junior Research Fellow, University of Sheffield, UK
- 2009 – 2010 Postdoc, University of Uppsala, Sweden
- 2008 PhD, University of Edinburgh, UK
1.1 Selected Distinctions
- 2024 Organizer of the International Conference Quantitative Genetics (ICQG)
- 2021 ELLIS Scholar
- 2019 Swiss National Science Foundation Eccellenza Award
- 2010 NERC Junior Research Fellowship
1.2 Selected Grants
- 2026 – 2031 Biotechnology and Biological Sciences Research Council (BBSRC) UK. co-PI, funding: 2 million GBP. Methylation Ageing by Lifestyle and Tissue biosample (MALT). Project number: APP53767.
- 2022 – 2025 Collaborative Research Agreement Boehringer Ingelheim International GmbH and Institute of Science and Technology. Sole lead applicant PI, funding: € 450,000. “Advanced statistical modelling of biobank data and clinical cohorts”.
- 2019 – 2025 Swiss National Science Foundation Eccellenza Award. Sole lead applicant PI, funding: 1.5 million CHF. “Improving estimation and prediction of common complex disease risk”. Project number: PCEGP3181181.
1.3 Tech Transfer (Patents, Spin-Offs)
N/A
1.4 Selected Publications
- A. Depope, J. Bajzik, M. Mondelli, and M. R. Robinson, “Joint modeling of whole-genome sequencing data for human height via approximate message passing,” Cell Genomics, 2026/04/21 DOI: 10.1016/j.xgen.2026.101162 [Online]. Available: https://doi.org/10.1016/j.xgen.2026.101162.
- I. Krätschmer et al., “Separating direct, indirect and parent-of-origin genetic effects in the human population,” in press Cell Genomics, p. 2025.04.28.650988, Jan. 2025. DOI: 10.1101/2025.04.28.650988 [Online]. Available: http://biorxiv.org/content/early/2025/08/27/2025.04.28.650988.abstract.
- S. E. Ojavee et al., “Genomic architecture and prediction of censored time-to-event phenotypes with a bayesian genome-wide analysis,” Nature Communications, vol. 12, no. 1, p. 2337, 2021. DOI: 10.1038/s41467-021-22538-w [Online]. Available: https://doi.org/10.1038/s41467-021-22538-w.
- E. J. Orliac et al., “Improving gwas discovery and genomic prediction accuracy in biobank data,” Proceedings of the National Academy of Sciences, vol. 119, no. 31, e2121279119, 2026/04/21. 2022. DOI: 10.1073/pnas.2121279119 [Online]. Available: https://doi.org/10.1073/pnas.2121279119.
- M. Borczyk et al., “Separating the genetics of disease, treatment, and treatment response using graphical modeling and large-scale electronic health records,” in press Nature Communications, p. 2025.04.29.25326633, Jan. 2026. DOI: 10.1101/2025.04.29.25326633 [Online]. Available:
http://medrxiv.org/content/early/2026/03/20/2025.04.29.25326633.abstract.
2 Group Members
- Al Depope, PhD Student since 2021 (co-advised with Marco Mondelli)
- Maria Adame Galeano, PhD Student since 2025 (co-advised with Beatriz Vicoso)
- Ekaterina Maksimova, PhD Student since 2021 (co-advised with Gašper Tkačik)
- Jakub Bajzik, Postdoc since 2023
- Pablo Cobo, Postdoc since 2026 (with Marco Mondelli)
- Shimeng Huang, Postdoc since 2025 (with Francesco Locatello)
- Ilse Kratschmer, Postdoc since 2021
3 Research
In a broad sense, the group’s research focus is to develop principled inference methods for long-standing questions in biology that utilize three novel data types which will become available over the medium-term: (i) the increasing diversity of different types of genomics data measures on the same individuals/cells; (ii) large-scale family data where the DNA of both parents and children are observed; and (iii) large-scale whole genome sequence data linked to electronic health records (EHRs).
3.1 Current Scientific Projects/Directions
- Statistical model development for high-dimensional repeated biomarker observations.
- Genetic models for family data, indirect genetic effects and imprinting.
- The genetic basis of recombination and it’s role as a source of mutation and epigenetic variation.
- Long-range sequencing of trio families to determine the genetic basis of innate immunity.
3.2 Research in Focus
There are four main contributions within the last seven years. First, we combined genomics and information theory to produce a precisely characterized efficient algorithm that yielded novel biological insight when applied to the first large-scale whole genome sequence (WGS) data (Depope et al.). We show that detecting associated DNA variants requires joint modeling of all WGS variants to control for data structure and that state-of-the art prediction of outcomes from the DNA can be obtained. This work offers a scalable foundation for a wider range of analyses across the life sciences.
Second, we introduced a modeling approach to estimate how DNA loci influence human traits by breaking down genetic influence into four key genetic components: direct genetic effects, the phenotypic associations of the child’s own alleles; maternal and paternal genetic effects, the phenotypic impact from the mother’s and father’s alleles; and parent-of-origin (PofO) effects, phenotypic variation attributable to which parent passed down the allele (Krätschmer et al.). By analyzing 30,000 child-mother-father trios we show that direct effects are the leading contributor to variation in height; body mass index (BMI); and childhood educational test scores (EA), but indirect parental genetic effects and parent-of-origin effects make an equivalent combined contribution.
Third, the genetic basis of between-individual variation in the occurrence and genomic location of meiotic recombination events remains poorly understood in humans. We addressed this by curating 112,144 maternal and 78,653 paternal meiosis events (parent-child pairs) across cohorts from four countries, creating the largest dataset of its kind. We identify 58 independent genomic regions, many of which have significant sex-dependent effects across studies (Krätschmer et al. in review). We estimate the between-sex genetic correlation for meiotic recombination rate to be 0.374 (0.072 SD), which captures the extent to which the genetic factors influencing a trait in one sex also impact the same trait in the other. 30-40% of the individual-level variation in recombination rate is attributable to DNA markers, we show that we can significantly predict recombination rates in other biobanks from the DNA and we find significant correlations between female meiotic recombination, reproductive outcomes and reproductive aging.
Finally, we derived a novel log-Weibull model, which allows separation of predictor effects on mean survival from the variance, that is suitable for a decreasing probability of survival as subjects gets older and empirically obtains better out-of-sample prediction over the state-of-the-art Cox-LASSO model (Ojavee et al.). With increasing linkage of repeated electronic health record data and ongoing algorithmic improvements this will detect age-at-onset associated DNA variants, separate genetic variants for different age-related diseases from the underlying aging process, and contribute toward early-detection and screening programs in the population. My PhD student was awarded the European Society of Human Genetics Lodewijk Sandkuijl Award for this work.